Table 1.
Function | miRNA | Target | Reference |
---|---|---|---|
Regulation of vascular development, growth, and differentiation | |||
miR-126 | Spredl | [44–49] | |
PIK3R2/p85-b | |||
miR-149 | Fgfrl | [32] | |
miR-149* | Gpcl | ||
miR-218 | Robo 1 | [50–52] | |
Robo2 | |||
Glce | |||
miR-17~92 | Elkl | [33■,53–55] | |
Itga5 | |||
Jakl | |||
Fzd4 | |||
miR-23–24–27 | Sprouty2 | [56–59] | |
Sema6A | |||
GATA2 | |||
PAK4 | |||
miR-132 | p120RasGAP | [27] | |
miR-221/222 | STAT5A | [30] | |
miR-150 | c-Myb | [60] | |
miR-210 | Efna3 | [61,62] | |
Ptplb | |||
Dapkl | |||
Ctgf | |||
miR-424 | Cul2 | [63] | |
miR-217 | Sirtl | [64] | |
miR-146 | Nox4 | [65] | |
miR-216a | Becnl | [66] | |
Regulation of barrier function | |||
miR-125 | Cadh5 | [67] | |
miR-147b | Adaml5 | [68] | |
Regulation of vascular tone | |||
miR-155 | eNOS | [69] | |
miR-133a | Gchl | [70■■] | |
miR-125a/b | Et-l | [71] | |
Control of leukocyte trafficking and inflammation | |||
miR-31 | E-sele | [72] | |
miR-17–3p | Icaml | [72] | |
miR-126 | Vcaml | [73] | |
miR-181b | Kpna4 | [74] | |
miR-10a | Map3k7 | [75,76,77■] | |
βTRC | |||
IRAK4 | |||
miR-146a/b | TRAF6 | [78] | |
IRAKl | |||
HuR | |||
Let-7g/a/b | Loxl | [79] | |
miR-365 | Bcl2 | [80] | |
miR-150 | c-Myb | [60] |
ADAM, disintegrin and metalloproteinase domain-containing protein; ADAM15, a disintegrin and metalloproteinase15; c-Myb, c- myeloblastosis transcription activator factor; Cul2, cullin 2; E-sele, E-selectin; GCH, GTP cyclohydrolase 1; HuR, human antigen R; Icam1, intracellular adhesion molecule1; Glce, glucuronyl C5-epimerase; Lox, lectin-like oxidized low-density lipoprotein receptor; miRNA, microRNA; PIK3R2, phosphoinositol-3 kinase regulatory subunit 2; Robo, roundabout receptors; Sema6A, semaphorin-6A; Sirt1; silent information regulator 1; Spred1, sprouty-related protein1, STAT, signal transducer and activator of transcription.
Passenger strand.